Tserio News News feeds from the largest sources

Mylan and Theravance's COPD treatment gets FDA approval
Theravance Biopharma Inc and partner Mylan NV on Friday won U.S. regulatory approval for their treatment for a chronic lung condition that causes breathing-related problems.
Mylan and Theravance's COPD treatment gets FDA approval